SLRX Market Cap History

Below is a table of the SLRX market cap history going back to 7/22/2019:

Date SLRX Market Cap

Also see: SLRX Shares Outstanding History
and SLRX YTD Return
SLRX Historical Market Cap:
-20.69% CAGR
SLRX Historical Market Cap: +-20.69% CAGR

Mouse over chart for data details
7/22/2019 ...11/6/2023
Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s pipeline consists of two compounds: seclidemstat (SP-2577), a small molecular inhibitor and SP-3164, a small molecular protein degrader. SP-2577 is a small-molecule lysine specific demethylase 1 (LSD1) inhibitor with a scaffold. LSD1 is an enzyme that is, in part, responsible for epigenetic regulation of genes that support cancer growth. SP-3164 is a cereblon binding molecular glue. SP-3164 degrades transcription factors IKZF1 and IKZF3, along with other proteins, resulting in both direct anti-cancer activity and immune-modulating properties. SP-3164 has activity in both hematologic and solid tumors. We show 18 historical shares outstanding datapoints in our SLRX shares outstanding history coverage, used to compute SLRX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SLRX market cap history over the course of time is important for investors interested in comparing SLRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SLRX versus a peer is one thing; comparing SLRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SLRX can fluctuate over the course of history. With this page we aim to empower investors researching SLRX by allowing them to research the SLRX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree SLRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Salarius Pharmaceuticals (SLRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

SLS Market Cap History
SMLR Market Cap History
SMMT Market Cap History
SMTI Market Cap History
SNBP Market Cap History
SNCA Market Cap History
SNDA Market Cap History
SNDX Market Cap History
SNGX Market Cap History
SNNA Market Cap History
More Healthcare companies »


SLRX Market Cap History | | Copyright © 2017 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.